DeepMed Research

ACTAVIS INC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis

Phase 3

Completed

Conditions: Actinic Keratosis

Interventions: Drug: Vehicle Foam
Drug: Generic Ingenol Mebutate
Drug: Ingenol Mebutate (Picato®)

First Posted Date: 2016-01-13

Last Posted Date: 2020-05-12

Lead Sponsor: Actavis Inc.

Target Recruit Count: 441

Registration Number: NCT02654769

Locations: 🇺🇸
Center for Dermatology Clinical Research, Inc, Fremont, California, United States
🇺🇸
SD Sports Medicine & Family Health Center, San Diego, California, United States
🇺🇸
The Center for Clinical and Cosmetic Research, Aventura, Florida, United States

and more 19 locations

Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris

Phase 3

Completed

Conditions: Acne

Interventions: Drug: Adapalene and Benzoyl Peroxide Gel
Drug: Epiduo® Forte Gel
Drug: placebo gel

First Posted Date: 2016-01-08

Last Posted Date: 2020-06-23

Lead Sponsor: Actavis Inc.

Target Recruit Count: 1001

Registration Number: NCT02651220

Locations: 🇧🇿
Site 117, Belize City, Belize
🇺🇸
Site 103, Mesa, Arizona, United States
🇺🇸
Site 112, Anaheim, California, United States

and more 17 locations

Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis

Phase 3

Completed

Conditions: Actinic Keratosis

Interventions: Drug: Generic Fluorouracil Cream
Drug: Vehicle Cream
Drug: Carac® (Fluorouracil) Cream

First Posted Date: 2015-11-30

Last Posted Date: 2019-07-17

Lead Sponsor: Actavis Inc.

Target Recruit Count: 422

Registration Number: NCT02616601

Locations: 🇺🇸
Investigative Site 17, San Diego, California, United States
🇺🇸
Investigative Site 3, Carmel, Indiana, United States
🇺🇸
Investigative Site 14, Philadelphia, Pennsylvania, United States

and more 14 locations

Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris

Phase 3

Completed

Conditions: Acne Vulgaris

Interventions: Drug: Clindamycin/benzoyl peroxide gel
Drug: Placebo
Drug: Onexton

First Posted Date: 2015-11-30

Last Posted Date: 2020-05-27

Lead Sponsor: Actavis Inc.

Target Recruit Count: 862

Registration Number: NCT02616614

Locations: 🇺🇸
Sundance Clinical Research, Saint Louis, Missouri, United States
🇺🇸
Estudy, La Mesa, California, United States
🇺🇸
Heartland Research Assoc, Wichita, Kansas, United States

and more 10 locations

Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes

Phase 3

Completed

Conditions: Glaucoma

Interventions: Drug: Test-Brinzolamide 1% Ophthalmic suspension
Drug: Reference-Brinzolamide 1% Ophthalmic suspension

First Posted Date: 2015-07-30

Last Posted Date: 2020-03-02

Lead Sponsor: Actavis Inc.

Target Recruit Count: 973

Registration Number: NCT02512042

Locations: 🇺🇸
Las Vegas Physicians Research Group, Henderson, Nevada, United States
🇺🇸
Shettle Eye Research, Inc., Largo, Florida, United States
🇺🇸
David Wirta, MD, Newport Beach, California, United States

and more 6 locations

Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's Diarrhea

Phase 3

Completed

Conditions: Diarrhea

Interventions: Drug: Xifaxan®
Drug: Placebo Tablet
Drug: Rifaximin

First Posted Date: 2015-07-15

Last Posted Date: 2019-12-05

Lead Sponsor: Actavis Inc.

Target Recruit Count: 739

Registration Number: NCT02498418

Locations: 🇺🇸
Site 1, Coral Gables, Florida, United States

Randomized, Placebo-controlled Study Comparing Efficacy of Fluticasone/Salmeterol Combination to Advair in Asthmatics

Phase 3

Withdrawn

Conditions: Asthma

Interventions: Drug: Fluticasone propionate 100 mcg / salmeterol 50 mcg
Drug: Placebo
Drug: Generic fluticasone propionate 100 mcg / salmeterol 50 mcg

First Posted Date: 2015-07-14

Last Posted Date: 2019-07-05

Lead Sponsor: Actavis Inc.

Registration Number: NCT02496715

Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants

Phase 3

Completed

Conditions: Asthma

Interventions: Drug: Generic Budesonide/Formoterol Fumarate Dihydrate
Drug: Symbicort® (Budesonide/Formoterol Fumarate Dihydrate)
Drug: Placebo

First Posted Date: 2015-07-13

Last Posted Date: 2019-11-29

Lead Sponsor: Actavis Inc.

Target Recruit Count: 1714

Registration Number: NCT02495168

Locations: 🇺🇸
Site 100, Surprise, Arizona, United States
🇺🇸
Site 101, Huntington Beach, California, United States
🇺🇸
111, San Jose, California, United States

and more 14 locations

A Study of Hyaluronate Injectable Viscosupplement for Treatment of Osteoarthritis of the Knee

Not Applicable

Completed

Conditions: Osteoarthritis

Interventions: Device: Euflexxa IA injection
Device: Hyaluronate Injectable Viscosupplement
Device: Placebo

First Posted Date: 2015-07-13

Last Posted Date: 2020-06-23

Lead Sponsor: Actavis Inc.

Target Recruit Count: 599

Registration Number: NCT02495857

Locations: 🇺🇸
Mehra, San Diego, California, United States
🇺🇸
Bretton, Albuquerque, New Mexico, United States

Safety and Efficacy of Generic Diclofenac Epolamine Acute Pain Due to Minor Ankle Sprain

Phase 3

Completed

Conditions: Ankle Sprain

Interventions: Drug: Diclofenac epolamine
Other: Placebo

First Posted Date: 2014-12-24

Last Posted Date: 2020-06-24

Lead Sponsor: Actavis Inc.

Target Recruit Count: 658

Registration Number: NCT02324270

Locations: 🇺🇸
Site 26, Lexington, Kentucky, United States
🇺🇸
Site 29, Berlin, New Jersey, United States
🇺🇸
Site 18, Brooklyn, New York, United States

and more 28 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy